Form 4: 10x Genomics CFO Justin J. McAnear Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Justin J. McAnear, CFO of 10x Genomics, sold shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On May 22, 2024, Justin J. McAnear, the Chief Financial Officer of 10x Genomics, Inc. (TXG), sold 2,936 shares of Class A Common Stock.
  • The sale was executed at a price of $24.3036 per share.
  • This transaction was to cover tax withholding obligations related to the vesting of restricted stock units.
  • Following the transaction, McAnear directly owns 146,203 shares of 10x Genomics, Inc.
  • This number includes 587 shares acquired through the Issuer's Employee Stock Purchase Plan on May 14, 2024.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives. This transaction is a routine part of executive compensation and financial planning.

Key Dates

DateDescription
05/14/2024McAnear acquired 587 shares through the Issuer's Employee Stock Purchase Plan.
05/22/2024McAnear sold 2,936 shares of Class A Common Stock at $24.3036 per share.
05/23/2024Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.